Nov 13 (Reuters)-
D.Western Therapeutics Institute Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2025 Sep 30, 2024 Dec 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 297 mln 348 mln 400 mln
(-14.9 pct) (+11.1 pct) (-15.2 pct)
Operating loss 478 mln loss 647 mln loss 670 mln
Recurring loss 491 mln loss 665 mln loss 680 mln
Net loss 492 mln loss 727 mln loss 680 mln
EPS loss 10.75 yen loss 21.61 yen loss 15.88 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - D.Western Therapeutics Institute Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4576.T